Techtimes
Published November 16, 2026 · Updated November 17, 2026
Psychedelic Add-On for Depression Beats Placebo by 7.6 Points in Phase 3, Blinding Data Missing
Read the full story at Techtimes
Psychedelic depression treatment HLP003 beat placebo by 7.6 MADRS points at Week 6 in Helus Pharma's first Phase 3 trial of an adjunctive.
Surfaced by this Google Alert
- Psychedelics